In the North American medical devices industry, there were 79 M&A deals announced in Q3 2024, worth a total value of $12.5bn, according to GlobalData’s Deals Database. The $3.8bn acquisition of Baxter International by Carlyle Group was the industry’s largest disclosed deal. GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes in Q3 2024 report helps understand the pivotal themes steering M&A activity in the industry. Buy the report here.
Smarter leaders trust GlobalData
In value terms, M&A activity in North America decreased by 37% in Q3 2024 compared with the previous quarter’s total of $19.9bn and rose by 709% as compared to Q3 2023. Related deal volume increased by 23% in Q3 2024 versus the previous quarter and was 41% higher than in Q3 2023.
The top-ranked financial advisors supporting these M&A deals in North America in 9M 2024 were Jefferies Financial Group; Citigroup; Evercore with 5, 3, 3 deals respectively.
The top-ranked legal advisors supporting these M&A deals in North America in 9M 2024 were Kirkland & Ellis; Weil, Gotshal & Manges; Ropes & Gray with 13, 6, 4 deals respectively.
For further understanding of GlobalData's Medical Devices Industry Mergers And Acquisitions Deals By Top Themes In Q3 2024 – Strategic Intelligence, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Acquisition, Asset transactions and Mergers.
